Fig. 8

The result of multivariate analysis showed that these hub gene marker have a stable performance in ICB prediction regardless of exsisting criteria. This result was consistent across all three data sets. a) Subgroup of PDL-1 combined tumor and immune cell score (+). b) Subgroup of PDL-1 combined tumor and immune cell score (-). c) Subgroup of p16 positivity (+). d) Subgroup of p16 positivity (-). e) Subgroup of PDL-1 Tumor Proportion Score (+). f) Subgroup of PDL-1 Tumor Proportion Score (-)